Nasdaq:US$20.09 (-0.08) | HKEX:HK$31.30 (-0.75) | AIM:£3.24 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 16 Apr 2023

AACR 2023: Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2